Pervasis Therapeutics Inc., a Cambridge, Mass.-based developer of regenerative cell-based therapies and devices, is seeking to raise $25 million in Series C funding, according to VentureWire.
Pervasis Therapeutics Inc., a Cambridge, Mass.-based developer of regenerative cell-based therapies and devices, is seeking to raise $25 million in Series C funding, according to VentureWire.
